Leading Public Health Officials to Present New Data and National Survey Findings
WHAT:
Amid a surge of COVID-19 cases, the availability of updated COVID-19 and influenza (flu) vaccines, and new guidance on respiratory syncytial disease (RSV) vaccination, leading national public health experts will present final 2023-2024 US respiratory disease season data and results from a new national survey of US adults on vaccination behaviors and attitudes around flu, RSV, COVID-19, and pneumococcal disease. Experts will also discuss the impact of these findings and how the public can best protect themselves this fall and winter.
Mandy K. Cohen, MD, MPH, Director, Centers for Disease Control and Prevention (CDC), will receive a flu vaccine during the news conference, and other panelists and advocates will also be vaccinated against flu at the onsite clinic following the news conference. A limited number of flu vaccines will be available for media attendees who register in advance.
WHO:
The National Foundation for Infectious Diseases (NFID) and CDC. Expert panelists include:
- Mandy K. Cohen, MD, MPH, CDC Director
- Demetre C. Daskalakis, MD, MPH, Director, National Center for Immunization and Respiratory Diseases, CDC
- Robert (Bob) H. Hopkins, Jr., MD, NFID Medical Director (Moderator)
- Flor M. Muñoz, MD, MSc, Associate Professor of Pediatrics, Infectious Diseases, Baylor College of Medicine; NFID Director
- Reed V. Tuckson, MD, Co-Founder of the Black Coalition Against COVID; Chair of the Board of the Coalition For Trust In Health & Science
WHEN:
Wednesday, September 25, 2024
News Conference: 9:00–10:00 AM ET
Flu Vaccine Clinic: 10:00-11:00 AM ET
WHERE:
Virtual
In-Person: National Press Club, 529 14th Street, NW, Holeman Lounge (13th Floor), Washington, DC 20045
Further instructions for in-person attendance will be provided following registration.
For more information, visit www.nfid.org/2024flunews.
Contact: IECommsNFID@inizioevoke.com
Recent Press Releases
Leading Health Organizations Urge Flu Vaccination for Those at Higher Risk
During National Influenza Vaccination Week, experts encourage everyone age 6 months and older to get vaccinated to reduce risk of severe illness and hospitalization
Adults Age 50 and Older Can Help Lower Risk for Pneumonia
NFID and the American Lung Association are working together to raise awareness about the importance of pneumococcal disease vaccination for those at risk
As Concerns about Respiratory Diseases Among Public Drop to New Lows, US Health Officials Urge Vaccination
New NFID survey shows fewer than 1 in 5 US adults are concerned about flu, COVID-19, RSV, or pneumococcal disease, and many do not plan to get vaccinated this fall and winter